234 related articles for article (PubMed ID: 23228009)
41. Magnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson's disease?
Ciurleo R; Di Lorenzo G; Bramanti P; Marino S
Biomed Res Int; 2014; 2014():519816. PubMed ID: 25302300
[TBL] [Abstract][Full Text] [Related]
42. Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla.
Stern AJ; Savostyanova AA; Goldman A; Barnett AS; van der Veen JW; Callicott JH; Mattay VS; Weinberger DR; Marenco S
Biol Psychiatry; 2008 Nov; 64(10):856-62. PubMed ID: 18707679
[TBL] [Abstract][Full Text] [Related]
43. Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliability.
Wiedermann D; Schuff N; Matson GB; Soher BJ; Du AT; Maudsley AA; Weiner MW
Magn Reson Imaging; 2001 Oct; 19(8):1073-80. PubMed ID: 11711231
[TBL] [Abstract][Full Text] [Related]
44. Metabolite differences in the lenticular nucleus in type 2 diabetes mellitus shown by proton MR spectroscopy.
Lin Y; Zhou J; Sha L; Li Y; Qu X; Liu L; Chen H; An Z; Wang Y; Sun C
AJNR Am J Neuroradiol; 2013 Sep; 34(9):1692-6. PubMed ID: 23598834
[TBL] [Abstract][Full Text] [Related]
45. Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.
Van Dalen YW; Blokhuis C; Cohen S; Ter Stege JA; Teunissen CE; Kuhle J; Kootstra NA; Scherpbier HJ; Kuijpers TW; Reiss P; Majoie CBLM; Caan MWA; Pajkrt D
Medicine (Baltimore); 2016 Mar; 95(12):e3093. PubMed ID: 27015179
[TBL] [Abstract][Full Text] [Related]
46. Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy.
Baik HM; Choe BY; Lee HK; Suh TS; Son BC; Lee JM
Korean J Radiol; 2002; 3(3):180-8. PubMed ID: 12271163
[TBL] [Abstract][Full Text] [Related]
47. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.
Zhu X; Schuff N; Kornak J; Soher B; Yaffe K; Kramer JH; Ezekiel F; Miller BL; Jagust WJ; Weiner MW
Alzheimer Dis Assoc Disord; 2006; 20(2):77-85. PubMed ID: 16772742
[TBL] [Abstract][Full Text] [Related]
48. Global brain metabolic quantification with whole-head proton MRS at 3 T.
Kirov II; Wu WE; Soher BJ; Davitz MS; Huang JH; Babb JS; Lazar M; Fatterpekar G; Gonen O
NMR Biomed; 2017 Oct; 30(10):. PubMed ID: 28678429
[TBL] [Abstract][Full Text] [Related]
49. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Sep; 22(7):1017-24. PubMed ID: 15288143
[TBL] [Abstract][Full Text] [Related]
50. Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson's disease.
Zhou B; Yuan F; He Z; Tan C
Brain Imaging Behav; 2014 Mar; 8(1):97-101. PubMed ID: 23955491
[TBL] [Abstract][Full Text] [Related]
51. MR image segmentation and tissue metabolite contrast in 1H spectroscopic imaging of normal and aging brain.
Lundbom N; Barnett A; Bonavita S; Patronas N; Rajapakse J; Tedeschi ; Di Chiro G
Magn Reson Med; 1999 Apr; 41(4):841-5. PubMed ID: 10332862
[TBL] [Abstract][Full Text] [Related]
52. MR-spectroscopy in metachromatic leukodystrophy: A model free approach and clinical correlation.
Feldmann J; Martin P; Bender B; Laugwitz L; Zizmare L; Trautwein C; Krägeloh-Mann I; Klose U; Groeschel S
Neuroimage Clin; 2023; 37():103296. PubMed ID: 36563646
[TBL] [Abstract][Full Text] [Related]
53. MRS study on lentiform nucleus in idiopathic Parkinson's disease with unilateral symptoms.
Zheng XN; Zhu XC; Ruan LX; Zhang LJ; Yuan M; Shang DS; Liu Y
J Zhejiang Univ Sci; 2004 Feb; 5(2):246-50. PubMed ID: 14674041
[TBL] [Abstract][Full Text] [Related]
54. Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients.
Lucetti C; Del Dotto P; Gambaccini G; Bernardini S; Bianchi MC; Tosetti M; Bonuccelli U
Neurol Sci; 2001 Feb; 22(1):69-70. PubMed ID: 11487206
[TBL] [Abstract][Full Text] [Related]
55. Value of single-voxel proton MR spectroscopy in temporal lobe epilepsy.
Achten E; Boon P; Van De Kerckhove T; Caemaert J; De Reuck J; Kunnen M
AJNR Am J Neuroradiol; 1997; 18(6):1131-9. PubMed ID: 9194441
[TBL] [Abstract][Full Text] [Related]
56. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
57. Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy.
Clarke CE; Lowry M
Eur J Neurol; 2000 Nov; 7(6):661-5. PubMed ID: 11136352
[TBL] [Abstract][Full Text] [Related]
58. The impact of acute and short-term methamphetamine abstinence on brain metabolites: A proton magnetic resonance spectroscopy chemical shift imaging study.
Burger A; Brooks SJ; Stein DJ; Howells FM
Drug Alcohol Depend; 2018 Apr; 185():226-237. PubMed ID: 29471227
[TBL] [Abstract][Full Text] [Related]
59. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.
Inglese M; Li BS; Rusinek H; Babb JS; Grossman RI; Gonen O
Magn Reson Med; 2003 Jul; 50(1):190-5. PubMed ID: 12815694
[TBL] [Abstract][Full Text] [Related]
60. Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy.
Nordahl TE; Salo R; Possin K; Gibson DR; Flynn N; Leamon M; Galloway GP; Pfefferbaum A; Spielman DM; Adalsteinsson E; Sullivan EV
Psychiatry Res; 2002 Nov; 116(1-2):43-52. PubMed ID: 12426033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]